Who we are
Scientific Officer: Prof. Ovidio Bussolati
- Amelia Barilli; Associate Professor, email: amelia.barilli@unipr.it ; tel. 3784
- Massimiliano Bianchi; RTD/a email: massimiliano.bianchi@unipr.it ; tel. 3784
- Ovidio Bussolati; Full Professor, email: ovidio.bussolati@unipr.it ; tel. 3783
- Mattia Castellucchio; PhD student, email mattia.castellucchio@unipr.it , tel. 3779
- Martina Chiu; RTD/b, email: martina.chiu@unipr.it ; tel. 3782
- Eleonora Crescini; PhD student, email: eleonora.crescini@unipr.it ; tel. 3779
- Valeria Dall'Asta; Honorary Professor, email: valeria.dallasta@unipr.it ; tel. 3787
- Bianca Maria Rotoli; Associate Professor, email: biancamaria.rotoli@unipr.it ; tel. 3785
- Giuseppe Taurino; Veronesi Foundation Fellow, email: giuseppe.taurino@unipr.it ; tel. 3782
- Chiara Ughini; PhD student, email: chiara.ughini@unipr.it ; tel. 3779
- Rossana Visigalli; Technical Manager , email: rossana.visigalli@unipr.it ; tel. 3778
For info and contacts: email:
ovidio.bussolati@unipr.it ; tel 3783
rossana.visigalli@unipr.it ; tel: 3778
Where we are
Integrated Bio-tech complex
Palazzina D, 2nd floor;
Via Volturno, 39
43125 Parma
What we do
-"Role of inflammatory cytokines on amino acid transport and metabolism in epithelial, vascular and innate immunity cells." Unipr funds.
-"Characterization of membrane transporters implicated in drug delivery in respiratory, normal and pathological epithelial cells." Research contract Chiesi Farmaceutici SpA/University of Parma.
-"Protein misfolding in neurodegenerative diseases: integrating BioinfoRmAtIcs and biochemistry for Natural compound therapies." Eugreen 2024 funds.
-"Gut and Parkinson's Disease: targeting the role of Clusterin chaperone activity to hamper the alpha-Synuclein aggregation process and its detrimental effects in enteric neurons." University Research Call 2024 - Action C.
-"Cytofluorimetric analysis of monocyte phenotype in subjects with colorectal cancer." Unipr funds.
- "Elucidating the role of multiple myeloma metabolic alterations in favoring bone lesions" (EROSION). PRIN 2022.
- "Unraveling the role of nanoplastics in multiple myeloma derived extracellular vesicles in educating bone microenvironment" (Nano-ULTRON). PRIN 2022 PNRR call.
-"Dissecting the metabolic interplay in multiple myeloma niche: Towards new druggable targets." University Call for Research 2024 - Action C. - "Dissecting nanoplastic effects on human macrophages." University Call for Research 2025 - Action B.
-"RNA-mEdiated immunomoduLation using nanomedIcine for the treatment of InflAmmatory BoweL DiseasE" (RELIABLE). European Union (ERA4Health NANOTECMEC 2024).
-"Towards a metabolic characterization of prostate cancer: implementation of an organoid-assembloid model to define glutamine and asparagine roles under realistic conditions." University Call for Research 2024 - Action A.
- "Glutamine secretion by activated macrophages boosts CD8+ lymphocyte activity." University Call for Research 2025 - Action B.
- "Identification of structural components of Bifidobacterium bifidum that can stimulate in vitro production of interferon γ by human immune cells." Research contract with GeneProbio srl/University of Parma (Microbiome Research Hub).
N.B. The premises occupied by the Laboratory of General Pathology also house the Laboratory of Biogentology and Geroscience (LBG, Head Prof. A. Bartolomucci).
